Wells Fargo's Brian Abrahams downgraded shares of Protalix BioTherapeutics (NYSE: PLX) from Outperform to Market Perform Monday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE